A severe case of Trichophyton rubrum-caused dermatomycosis exacerbated after COVID-19 vaccination that had to be differentiated from pustular psoriasis

Yuta Norimatsu; Yurie Norimatsu

Medical Mycology Case Reports (Jun 2022)

A severe case of Trichophyton rubrum-caused dermatomycosis exacerbated after COVID-19 vaccination that had to be differentiated from pustular psoriasis

Yuta Norimatsu,
Yurie Norimatsu

Affiliations

Yuta Norimatsu: Department of Dermatology, University of Tokyo Graduate School of Medicine, 113-8655, 7-3-1,Hongo, Bunkyo-ku, Tokyo, Japan; Department of Dermatology, Ageo Daiichi Clinic for Internal Medicine and Pediatrics, 362-0064, 845-1 Koshikidani, Ageo, Saitama, Japan; Corresponding author. Department of Dermatology, University of Tokyo Graduate School of Medicine, 113-8655, 7-3-1,Hongo, Bunkyo-ku, Tokyo, Japan.
Yurie Norimatsu: Department of Dermatology, Ageo Daiichi Clinic for Internal Medicine and Pediatrics, 362-0064, 845-1 Koshikidani, Ageo, Saitama, Japan

Journal volume & issue: Vol. 36
pp. 19 – 22

Abstract

Read online

We present a case of deep dermatomycosis caused by Trichophyton rubrum that developed after administration of SARS-CoV-2 BNT162b2 vaccination.A 75-year-old man was vaccinated with SARS-CoV-2 on day 0 and day 23. From day 25, pustules began to appear.A skin biopsy was performed. Tissue culture revealed the presence of Trichophyton rubrum.The patient was treated with topical luliconazole and 100 mg/day oral fosravuconazole for 84 days, after which the symptoms resolved.

Published in Medical Mycology Case Reports

ISSN: 2211-7539 (Online)
Publisher: Elsevier
Country of publisher: Netherlands
LCC subjects: Medicine: Medicine (General); Science: Biology (General)
Website: https://www.journals.elsevier.com/medical-mycology-case-reports/

About the journal

Abstract

Keywords